Capsida Biotherapeutics

Last updated: May 05, 2024

CEO Robert Cuddihy
CEO Robert Cuddihy
Country: USA | Funding: $140M (+)

Website: https://capsida.com/

Capsida develops targeted gene therapies in serious neurodegenerative diseases.